-----BEGIN PRIVACY-ENHANCED MESSAGE-----
Proc-Type: 2001,MIC-CLEAR
Originator-Name: webmaster@www.sec.gov
Originator-Key-Asymmetric:
 MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen
 TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB
MIC-Info: RSA-MD5,RSA,
 OiyIg5ynqb84njf8/lAwkKjr3upL4heiL9xGHU/sTK2mOwFZK21BajFPGNMQC3ve
 88GmNiAiNucsVb5RHarpuQ==

<SEC-DOCUMENT>0000700945-99-000006.txt : 19991018
<SEC-HEADER>0000700945-99-000006.hdr.sgml : 19991018
ACCESSION NUMBER:		0000700945-99-000006
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		2
CONFORMED PERIOD OF REPORT:	19990924
ITEM INFORMATION:		
FILED AS OF DATE:		19991001

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			GISH BIOMEDICAL INC
		CENTRAL INDEX KEY:			0000700945
		STANDARD INDUSTRIAL CLASSIFICATION:	SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
		IRS NUMBER:				953046028
		STATE OF INCORPORATION:			CA
		FISCAL YEAR END:			0630

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		
		SEC FILE NUMBER:	000-10728
		FILM NUMBER:		99721480

	BUSINESS ADDRESS:	
		STREET 1:		2681 KELVIN AVE
		CITY:			IRVINE
		STATE:			CA
		ZIP:			92714
		BUSINESS PHONE:		9497565485

	MAIL ADDRESS:	
		STREET 1:		2681 KELVIN AVE
		CITY:			IRVINE
		STATE:			CA
		ZIP:			92714
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<DESCRIPTION>ITEM 5
<TEXT>


                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549


                                    FORM 8-K
                                 CURRENT REPORT

     Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934


                Date of Report (Date of Earliest Event Reported)

                               September 24, 1999


                              GISH BIOMEDICAL, INC.
             (Exact name of registrant as specified in its charter)


                                   California
         (State of other jurisdiction of incorporation or organization)


        0-10728                                       95-3046028
(Commission File Number)               (I.R.S. Employer Identification Number)

        2681 Kelvin Avenue
        Irvine, California                                    92614
(Address of principal executive offices)                    (Zip Code)


               Registrant's telephone number, including area code
                                 (949) 756-5485


<PAGE>


Item 5.     Other Events

On September 24, 1999, the Company  announced a 23 percent reduction in its work
force, with the objective of reducing  operating costs.  Severance costs related
to the  reduction  in  personnel  of  approximately  $100,000 are expected to be
charged to operations in the quarter ending September 30, 1999.


Item 7.           Exhibits

Exhibit No.       Description
- ----------        -----------

99.1              Press Release Dated September 24, 1999


                                   SIGNATURES


Pursuant  to the  requirements  of the  Securities  Exchange  Act of  1934,  the
registrant  has duly  caused  this  report  to be  signed  on its  behalf by the
undersigned hereunto duly authorized.

                                                     Gish Biomedical, Inc.
                                                  -----------------------------
                                                          (Registrant)


                                             By  /s/   JAMES R. TALEVICH
                                                  -----------------------------
                                                       James R. Talevich
                                                     Vice President/CFO


                                             Date    September 30, 1999
                                                  -----------------------------


</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99
<SEQUENCE>2
<DESCRIPTION>PRESS RELEASE
<TEXT>


                                  EXHIBIT 99.1

                     PRESS RELEASE DATED SEPTEMBER 24, 1999


GISH BIOMEDICAL ANNOUNCES STREAMLINING OF WORK FORCE

Irvine, California-September 24, 1999-The Board of Directors of Gish Biomedical,
Inc.  (Nasdaq:GISH)  today  announced a 23%  reduction  in its work  force.  The
Company is  continuing to evaluate all possible  further cost savings  measures.
These moves are steps to increase Gish's competitive position in the marketplace
and to decrease its overhead and production  costs.  Severance  costs related to
the reduction in personnel of approximately  $100,000 are expected to be charged
to operations in the quarter ending September 30, 1999.


Gish Biomedical designs and manufactures  disposable medical devices for various
surgical  specialties  including   cardiovascular  surgery,   orthopedics,   and
oncology.   Currently  there  are  3,473,862   shares  of  Gish's  common  stock
outstanding.

This news release contains  forward-looking  statements concerning the Company's
business  and  products.  Actual  results may differ  materially  depending on a
number of risk factors,  including the impact of competition,  downward  pricing
pressures in the relevant markets,  risks related to product performance and the
risks relating to consumer acceptance of the Company's products. These and other
risks  inherent  in the  Company's  business  are  described  in  the  Company's
Securities and Exchange Commission filings,  including its Annual Report on Form
10-K.  The  Company  undertakes  no  obligation  to revise  the  forward-looking
statements  contained herein to reflect events or  circumstances  after the date
hereof or to reflect the occurrence of unanticipated events.


</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
-----END PRIVACY-ENHANCED MESSAGE-----